Ambirsentan supply shortage in France

The French National Agency for Medicines reports supply tensions for ambrisentan, a treatment for pulmonary arterial hypertension.

Published 7sem1 sourceupdated 4j

≈ 16sSpeed

The fact

This Viatris-produced drug is vital for 2,500 patients in France.

Health authorities are seeking solutions to prevent stock shortages.

Click the link to read an article on the topic:

Explore this topic

Auto-synthesis from 1 media source · identified on June 26, 2026